Fritextsökning
Innehållstyper
-
600 million SEK for life science - "Should not be the country of moderation"
Sweden will prioritize excellence over breadth in research. This was made clear when the government presented the research proposition for the next four years.
-
ZEISS Connected Quality: One metrology hub
The new product family ZEISS CONNECTED QUALITY is the solution for quick and secure data exchange, quality management and efficient system monitoring.
-
RegSmart Life Science AB
-
WuXi AppTec, UK Ltd
-
Novo Nordisk establishes new factory in Denmark
Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.
-
Medicon Valley Alliance
-
Joy at Egetis after positive CHMP opinion – ”The single most important milestone”
Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."
-
Mercodia AB
-
Galderma
-
Truly Labs AB
-
Aurevia
-
SGS Fimko Ltd.
-
ZEISS Insights: Measurement of bone plates and screws
Get free access to technical paper.
-
Prövning av pillervaccin mot covid-19 avbryts i USA
Det amerikanska hälsodepartementet har beordrat stopp för en statligt finansierad fas IIb-studie som skulle utvärdera ett potentiellt pillervaccin mot covid-19.
-
JMP Statistical Discovery
-
QPS Netherlands B.V
-
Festo liquid dispensing: going fast and slow
Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs
-
Spatial Biology Studies in Lung Tissue using Spectral Microscopy
Spectral imaging with the ZEISS LSM 980 laser scanning confocal enables more complex studies of cell-cell interactions and locations in immunology research.
-
Brexit creeping closer – or?
In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.
-
ProPharma
-
CTC Clinical Trial Consultants AB
-
Clinigen Clinical Supplies Management GmbH
-
EMA review confirms a risk of new cancer after CAR-T
CAR-T cancer therapies can, in rare cases, induce secondary cancers. The European Medicines Agency (EMA) now recognises this and requires a warning label to be ...
-
Anna Törner: ”If I fall seriously ill, I’ll move to Finland”
”It is both undignified and undemocratic that cancer patients must travel to Finland to uphold a façade of fairness that does not truly exist”, Anna Törner writes in a column.